We provide you with 20 years of free, institutional-grade data for IRON stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRON. Explore the full financial landscape of IRON stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$5,933,837
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Yu Jonathan Yen-Wen | Sale | -300 | $72.5 | $21,750 | 2026-06-30 |
| Yu Jonathan Yen-Wen | Derivatives Exercise | 300 | 2026-06-30 | ||
| Khara Rahul | Sale | -2,500 | $75 | $187,500 | 2026-06-30 |
| Khara Rahul | Derivatives Exercise | 2,500 | 2026-06-30 | ||
| Yu Jonathan Yen-Wen | Sale | -9,700 | $72.66 | $704,795 | 2026-06-24 |
| Yu Jonathan Yen-Wen | Derivatives Exercise | 9,700 | 2026-06-24 | ||
| Khara Rahul | Sale | -7,500 | $69.94 | $524,567 | 2026-06-23 |
| Khara Rahul | Derivatives Exercise | 7,500 | 2026-06-23 | ||
| Quisel John D | Sale | -34,000 | $69.92 | $2,377,226 | 2026-06-23 |
| Quisel John D | Derivatives Exercise | 34,000 | 2026-06-23 | ||
| Yu Jonathan Yen-Wen | Sale | -18,612 | $68.76 | $1,279,728 | 2026-06-18 |
| Yu Jonathan Yen-Wen | Derivatives Exercise | 18,612 | 2026-06-18 | ||
| Franchi Jean M. | Sale | -6,657 | $69 | $459,333 | 2026-04-15 |
| Savage William Jacob | Sale | -5,731 | $66.12 | $378,939 | 2026-04-15 |
| Savage William Jacob | Sale | -7,378 | $65.52 | $483,420 | 2026-03-04 |
| Franchi Jean M. | Sale | -353 | $69.06 | $24,377 | 2026-02-27 |
| Franchi Jean M. | Sale | -11,156 | $62.86 | $701,266 | 2026-02-19 |
| Stephenson Pamela | Sale | -5,531 | $62.86 | $347,679 | 2026-02-17 |
| Savage William Jacob | Sale | -3,256 | $62.86 | $204,672 | 2026-02-17 |
| Yu Jonathan Yen-Wen | Sale | -3,231 | $62.86 | $203,101 | 2026-02-17 |
| Quisel John D | Sale | -13,264 | $62.86 | $833,775 | 2026-02-17 |
| Savage William Jacob | Derivatives Exercise | 3,143 | 2025-12-29 | ||
| Quisel John D | Derivatives Exercise | 12,300 | 2025-12-19 | ||
| Bitterman Kevin | Sale | -148 | $91.47 | $13,538 | 2025-12-18 |
| Bitterman Kevin | Sale | -213 | $91.47 | $19,483 | 2025-12-18 |
| Bitterman Kevin | Sale | -393 | $91.47 | $35,948 | 2025-12-18 |
| Bitterman Kevin | Sale | -36,839 | $92.05 | $3,391,030 | 2025-12-16 |
| Bitterman Kevin | Sale | -47,851 | $92.05 | $4,404,685 | 2025-12-16 |
| Bitterman Kevin | Sale | -92,433 | $92.05 | $8,508,458 | 2025-12-16 |
| Bitterman Kevin | Sale | -7,000 | $91.87 | $643,090 | 2025-12-16 |
| Bitterman Kevin | Derivatives Exercise | 7,000 | 2025-12-16 | ||
| Savage William Jacob | Sale | -13,093 | $90.6 | $1,186,274 | 2025-12-16 |
| Yu Jonathan Yen-Wen | Sale | -30,000 | $83.15 | $2,494,359 | 2025-11-13 |
| Yu Jonathan Yen-Wen | Derivatives Exercise | 30,000 | 2025-11-13 | ||
| AI DMI LLC | Sale | -744,047 | $80.47 | $59,873,462 | 2025-10-24 |
| Bitterman Kevin | Sale | -35,000 | $84.89 | $2,971,150 | 2025-10-17 |
| Bitterman Kevin | Sale | -58,585 | $77.16 | $4,520,419 | 2025-10-17 |
| Bitterman Kevin | Sale | -90,000 | $68.01 | $6,120,900 | 2025-10-09 |
| Quisel John D | Derivatives Exercise | 10,000 | 2025-09-11 | ||
| Bitterman Kevin | Sale | -2,287 | $61.03 | $139,576 | 2025-08-26 |
| Bitterman Kevin | Sale | -32,174 | $61.15 | $1,967,440 | 2025-08-15 |
| Bitterman Kevin | Sale | -395 | $60.95 | $24,075 | 2025-08-07 |
| Bitterman Kevin | Sale | -8,492 | $61.04 | $518,352 | 2025-08-01 |
| Bitterman Kevin | Sale | -42,870 | $60.97 | $2,613,784 | 2025-07-25 |
| Bitterman Kevin | Sale | -664 | $61.13 | $40,590 | 2025-07-22 |
| Franchi Jean M. | Sale | -2,031 | $59 | $119,829 | 2025-07-18 |
| Franchi Jean M. | Sale | -2,000 | $57.5 | $115,000 | 2025-07-14 |
| Quisel John D | Sale | -34,800 | $55.23 | $1,922,046 | 2025-07-11 |
| Quisel John D | Derivatives Exercise | 34,800 | 2025-07-11 | ||
| Quisel John D | Sale | -5,200 | $55.09 | $286,454 | 2025-07-08 |
| Quisel John D | Derivatives Exercise | 5,200 | 2025-07-08 | ||
| Savage William Jacob | Derivatives Exercise | 32,070 | 2025-07-01 | ||
| Franchi Jean M. | Sale | -2,000 | $52.26 | $104,519 | 2025-06-18 |
| Savage William Jacob | Sale | -2,996 | $50 | $149,800 | 2025-06-09 |
| Savage William Jacob | Sale | -6,677 | $50.04 | $334,128 | 2025-05-22 |
| Savage William Jacob | Sale | -2,100 | $50.17 | $105,367 | 2025-05-06 |
| Quisel John D | Derivatives Exercise | 7,000 | 2025-04-08 | ||
| Ashiya Mona | Sale | -756 | $54.11 | $40,907 | 2025-03-26 |
| Ashiya Mona | Sale | -3,026 | $54.11 | $163,737 | 2025-03-26 |
| Ashiya Mona | Sale | -1,956 | $54.11 | $105,839 | 2025-03-26 |
| ORBIMED ADVISORS LLC | Sale | -756 | $54.11 | $40,907 | 2025-03-26 |
| ORBIMED ADVISORS LLC | Sale | -3,026 | $54.11 | $163,737 | 2025-03-26 |
| ORBIMED ADVISORS LLC | Sale | -1,956 | $54.11 | $105,839 | 2025-03-26 |
| Ashiya Mona | Sale | -6,912 | $54.02 | $373,386 | 2025-03-21 |
| Ashiya Mona | Sale | -27,647 | $54.02 | $1,493,491 | 2025-03-21 |
| Ashiya Mona | Sale | -17,870 | $54.02 | $965,337 | 2025-03-21 |
| ORBIMED ADVISORS LLC | Sale | -6,912 | $54.02 | $373,386 | 2025-03-21 |
| ORBIMED ADVISORS LLC | Sale | -27,647 | $54.02 | $1,493,491 | 2025-03-21 |
| ORBIMED ADVISORS LLC | Sale | -17,870 | $54.02 | $965,337 | 2025-03-21 |
| Ashiya Mona | Sale | -41,182 | $54.29 | $2,235,771 | 2025-03-12 |
| Ashiya Mona | Sale | -164,725 | $54.29 | $8,942,920 | 2025-03-12 |
| Ashiya Mona | Sale | -106,477 | $54.29 | $5,780,636 | 2025-03-12 |
| ORBIMED ADVISORS LLC | Sale | -41,182 | $54.29 | $2,235,771 | 2025-03-12 |
| ORBIMED ADVISORS LLC | Sale | -164,725 | $54.29 | $8,942,920 | 2025-03-12 |
| ORBIMED ADVISORS LLC | Sale | -106,477 | $54.29 | $5,780,636 | 2025-03-12 |
| Stephenson Pamela | Sale | -3,137 | $54.58 | $171,217 | 2025-02-20 |
| Yu Jonathan Yen-Wen | Sale | -1,610 | $54.58 | $87,874 | 2025-02-20 |
| Savage William Jacob | Sale | -1,638 | $54.58 | $89,402 | 2025-02-20 |
| Khara Rahul | Sale | -1,161 | $54.58 | $63,367 | 2025-02-20 |
The information provided in this report about IRON stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Disc Medicine Inc.(NASDAQ:IRON) 
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.
Website: https://www.discmedicine.com/
Founded: 2017
CEO: John Quisel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends